Company Filing History:
Years Active: 2000-2003
Title: The Innovative Contributions of Soonpin Yei
Introduction
Soonpin Yei is a notable inventor based in Carlsbad, California. He has made significant contributions to the field of biotechnology, particularly in the development of ribozyme technologies. With a total of 3 patents to his name, Yei's work has the potential to impact various medical applications.
Latest Patents
One of Yei's latest patents is focused on gene functional analysis and discovery using randomized or target-specific ribozyme gene vector libraries. This invention provides a hairpin ribozyme library that has a randomized recognition sequence, which is packaged in a vector and operably linked to a promoter suitable for high-level expression in a wide variety of cells. The invention comprises using the library in various selection protocols for identifying, isolating, and characterizing known or unknown target RNAs. This can reveal the phenotypic effects of such cleavage and identify the gene products that produce those phenotypic effects.
Another significant patent by Yei involves Hepatitis C Virus ribozymes. This invention provides ribozymes that are useful in treating or preventing Hepatitis C Virus (HCV) infection or disease in an organism or subject. It also includes methods of treating an HCV infection or disease, along with reagents such as vectors, host cells, and DNA molecules coding for these ribozymes that are useful in methods of treatment and prevention of HCV infection or disease.
Career Highlights
Yei is currently associated with Immusol, Incorporated, where he continues to innovate in the field of biotechnology. His work has garnered attention for its potential applications in medical treatments and research.
Collaborations
Some of Yei's notable coworkers include Jack R Barber and Peter J Welch, who have collaborated with him on various projects.
Conclusion
Soonpin Yei's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing medical science. His work in ribozyme technology holds promise for future treatments and research in combating viral infections.